Your Navigation:PCAR > Abstract
Search pcar
检索项:
检索词:
Abstract
Pharmaceutical Care and Research: 2018; 18(6):423,433,469
DOI: 10.5428/pcar20180607
Effect of hyperfunction of kidney on vancomycin dosage in patients with septic shock
1. ZHONG Han(a hannahzhong22@gmail.com)
2. ZHANG ZaiLi(a )
3. CUI Min(a )
4. et al(a )
Welcome to PCAR! You are the number 50 reader of this article!
Please cite this article as:
ZHONG Han,ZHANG ZaiLi,CUI Min,et al,. Effect of hyperfunction of kidney on vancomycin dosage in patients with septic shock[J]. Pharmaceutical Care and Research / yao xue fu wu yu yan jiu. 2018; 18(6): 423,433,469.
References:
1. Rhodes A,Evans L E,Alhazzani W,et al.Surviving sepsis campaign:international guidelines for management of sepsis and septic shock:2016[J].Intensive Care Med,2017,43(3):304-377.
2. CHU Yang,LUO YiFan,QU LianYue,et al.Application of vancomycin in patients with varying renal function,especially those with augmented renal clearance[J].Pharm Biol,2016,54(12):2802-2806.
3. Solomkin J S,Mazuski J E,Bradley J S,et al.Diagnosis and management of complicated intra-abdominal infection in adults and children:guidelines by the Surgical Infection Society and the Infectious Diseases Society of America[J].Clin Infect Dis,2010,50(2):133-164.
4. YE ZhiKang,CHEN YaoLong,CHEN Ken,et al.Therapeutic drug monitoring of vancomycin:a guideline of the Division of Therapeutic Drug Monitoring,Chinese Pharmacological Society[J].J Antimicrob Chemother,2016,71(11):3020-3025.
5. Bilbao-Meseguer I,Rodríguez-Gascón A,Barrasa H,et al.Augmented renal clearance in critically ill patients:a systematic review[J].Clin Pharmacokinet,2018,57(9):1107-1121.
6. Claus B O M,Hoste E A,Colpaert K,et al.Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy[J].J Crit Care,2013,28(5):695-700.
7. Carlier M,Carrette S,Roberts J A,et al.Meropenem and piperacillin/tazobactam prescribing in critically ill patients:does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?[J].Crit Care,2013,17(3):r84.
8. Udy A A,Lipman J,Jarrett P,et al.Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?[J].Crit Care,2015,19(1):28.
9. Baptista J P,Roberts J A,Sousa E,et al.Decreasing the time to achieve therapeutic vancomycin concentrations in critically ill patients:developing and testing of a dosing nomogram[J].Crit Care,2014,18(6):654.
10. Baptista J P,Sousa E,Martins P J,et al.Augmented renal clearance in septic patients and implications for vancomycin optimisation[J].Int J Antimicrob Agents,2012,39(5):420-423.
11. Sime F B,Udy A A,Roberts J A.Augmented renal clearance in critically ill patients:etiology,definition and implications for beta-lactam dose optimization[J].Curr Opin Pharmacol,2015,24:1-6.
12. Shimamoto Y,Fukuda T,Tanaka K,et al.Systemic inflammatory response syndrome criteria and vancomycin dose requirement in patients with sepsis[J].Intensive Care Med,2013,39(7):1247-1252.
《药学服务与研究》杂志社 All Rights Reserved 网站备案号:鲁B2-20061008
·地址:上海市杨浦区长海路168号18号楼东三楼 邮政编码:200433
·联系电话(传真):86-21-65519829, 021-31162330
·电子邮件:PharmCR@vip.163.com
·技术支持:中国康网
管理员入口